Evaluation of a New Local Drug Delivery in the Nonsurgical Treatment of Periodontitis
Primary Purpose
Periodontitis
Status
Unknown status
Phase
Phase 2
Locations
Poland
Study Type
Interventional
Intervention
new local drug delivery
scaling root planing
Sponsored by
About this trial
This is an interventional treatment trial for Periodontitis
Eligibility Criteria
Inclusion Criteria:
- stage- 3rd degree generalized periodontitis
- stage 4th degree generalized periodontitis
Exclusion Criteria:
- presence of general diseases affecting the clinical condition of the periodontium,
- hypersensitivity to the drug used in the carrier system,
- lack of proper oral hygiene
- active nicotinism
- age over 65 years
Sites / Locations
- Jacek ZborowskiRecruiting
- Wroclaw Medical University
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
scaling root planning
scaling root planning with new local drug delivery
Arm Description
patients in this group will have a scaling root planing procedure only
patients in this group will have a scaling root planing procedure and a drug administered
Outcomes
Primary Outcome Measures
changes in PD (pocket depth in millimetres )
Change in depth of periodontal pockets measured from the bottom of the pocket to the edge of the gum in millimetres using periodontal probe
changes in CAL (clinical attachment level in millimetres )
Change in clinical attachment level of periodontal pockets measured from the Cement-enamel junction to the bottom of the pocket in millimetres using periodontal probe
changes in microbiome (rt PCR test)
change in microbiological and biochemical parameters of pocket microbiome using PCR real time test 3 months after Local dryg delivery (LDD) application( taken from the gingival pocket with gingival fluid with a paper filter. There will be six bacterial strains and the bacterial total load assessed)
Secondary Outcome Measures
Full Information
NCT ID
NCT04862819
First Posted
March 2, 2021
Last Updated
April 22, 2021
Sponsor
Wroclaw Medical University
1. Study Identification
Unique Protocol Identification Number
NCT04862819
Brief Title
Evaluation of a New Local Drug Delivery in the Nonsurgical Treatment of Periodontitis
Official Title
Clinical, Biochemical and Microbiological Evaluation of a New Local Drug Delivery in the Nonsurgical Treatment of Periodontitis
Study Type
Interventional
2. Study Status
Record Verification Date
January 2021
Overall Recruitment Status
Unknown status
Study Start Date
January 2, 2021 (Actual)
Primary Completion Date
November 1, 2021 (Anticipated)
Study Completion Date
December 30, 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Wroclaw Medical University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of the planned randomized clinical trial will be the clinical and microbiological evaluation of the new intracellular drug developed in cooperation with the Chair and Department of Drug Form Technology of the Medical University and the Department and Department of Pharmaceutical Microbiology and Parasitology of the Medical University in Wrocław.
Detailed Description
Clinical trials will be conducted on 60 patients of the Department of Periodontology of the Medical University of Wrocław with 3rd or 4th degree generalized periodontitis, who will consent to participate in the research by signing the documentation approved by the Bioethics Committee of our University. The exclusion criteria will be: the presence of general diseases affecting the clinical condition of the periodontium, hypersensitivity to the drug used in the carrier system, lack of proper oral hygiene, active nicotinism and age over 65 years. The research will be carried out according to the scheme of parallel randomization and double-blinded trial in two groups of 30 people. All qualified patients will undergo an initial period of periodontal treatment and scaling / root planning.
In the first group, on one side of the dental arch, the drug under evaluation will be used, and on the other side, placebo with a change of side in every second patient. In the other group, the drug under evaluation or placebo will be used on one side, and the SRP treatment with alternation of sides on the other side for every second patient.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Periodontitis
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Crossover Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
scaling root planning
Arm Type
Active Comparator
Arm Description
patients in this group will have a scaling root planing procedure only
Arm Title
scaling root planning with new local drug delivery
Arm Type
Experimental
Arm Description
patients in this group will have a scaling root planing procedure and a drug administered
Intervention Type
Drug
Intervention Name(s)
new local drug delivery
Other Intervention Name(s)
New LDD
Intervention Description
In the first group, on one side of the dental arch, the drug under evaluation will be used, and on the other side srp
Intervention Type
Procedure
Intervention Name(s)
scaling root planing
Other Intervention Name(s)
Scaling root planing (gold standard treatment)
Intervention Description
In the second group, on one side of the dental arch srp will be performed
Primary Outcome Measure Information:
Title
changes in PD (pocket depth in millimetres )
Description
Change in depth of periodontal pockets measured from the bottom of the pocket to the edge of the gum in millimetres using periodontal probe
Time Frame
3 month
Title
changes in CAL (clinical attachment level in millimetres )
Description
Change in clinical attachment level of periodontal pockets measured from the Cement-enamel junction to the bottom of the pocket in millimetres using periodontal probe
Time Frame
3 month
Title
changes in microbiome (rt PCR test)
Description
change in microbiological and biochemical parameters of pocket microbiome using PCR real time test 3 months after Local dryg delivery (LDD) application( taken from the gingival pocket with gingival fluid with a paper filter. There will be six bacterial strains and the bacterial total load assessed)
Time Frame
3 month
10. Eligibility
Sex
All
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
stage- 3rd degree generalized periodontitis
stage 4th degree generalized periodontitis
Exclusion Criteria:
presence of general diseases affecting the clinical condition of the periodontium,
hypersensitivity to the drug used in the carrier system,
lack of proper oral hygiene
active nicotinism
age over 65 years
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
jacek zborowski, phd
Phone
0048668446828
Email
jacek.zborowski@umed.wroc.pl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Małgorzata Szulc, phd
Organizational Affiliation
wroclaw medical univeristy
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Tomasz Konopka, prof
Organizational Affiliation
wroclaw medical univeristy
Official's Role
Principal Investigator
Facility Information:
Facility Name
Jacek Zborowski
City
Wrocław
State/Province
Dolnoslaskie
ZIP/Postal Code
52-311
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
jacek zborowski, phd
Email
jacekzborowski@gmail.com
Facility Name
Wroclaw Medical University
City
Wrocław
ZIP/Postal Code
52129
Country
Poland
Individual Site Status
Enrolling by invitation
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Evaluation of a New Local Drug Delivery in the Nonsurgical Treatment of Periodontitis
We'll reach out to this number within 24 hrs